Preoperative Methylene Blue Administration in Patients at High Risk for Vasoplegic Syndrome During Cardiac Surgery

This publication has 10 references indexed in Scilit:

• Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery
  The Annals of Thoracic Surgery, 2004
• Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function
  The Annals of Thoracic Surgery, 2001
• Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass
  The Journal of Thoracic and Cardiovascular Surgery, 2000
• Cardiopulmonary bypass increases plasma bradykinin concentrations
  Immunopharmacology, 1999
• Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery
  The Journal of Thoracic and Cardiovascular Surgery, 1999
• Systemic inflammatory response syndrome after cardiac operations
  The Annals of Thoracic Surgery, 1996
• Low systemic vascular resistance during cardiac surgery: Case reports, brief review, and management with angiotensin II
  Journal of Cardiothoracic Anesthesia, 1990
• Peripheral vascular resistance and angiotensin II levels during pulsatile and no-pulsatile cardiopulmonary bypass.
  Thorax, 1979